Anti-™EM56 monoclonal antibody
Pre-made anti-™EM56 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to ™EM56/™EM56 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2112-Ab-1/ GM-Tg-hg-IP2112-Ab-2 | Anti-Human ™EM56 monoclonal antibody | Human |
GM-Tg-rg-IP2112-Ab-1/ GM-Tg-rg-IP2112-Ab-2 | Anti-Rat ™EM56 monoclonal antibody | Rat |
GM-Tg-mg-IP2112-Ab-1/ GM-Tg-mg-IP2112-Ab-2 | Anti-Mouse ™EM56 monoclonal antibody | Mouse |
GM-Tg-cynog-IP2112-Ab-1/ GM-Tg-cynog-IP2112-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ™EM56 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2112-Ab-1/ GM-Tg-felg-IP2112-Ab-2 | Anti-Feline ™EM56 monoclonal antibody | Feline |
GM-Tg-cang-IP2112-Ab-1/ GM-Tg-cang-IP2112-Ab-2 | Anti-Canine ™EM56 monoclonal antibody | Canine |
GM-Tg-bovg-IP2112-Ab-1/ GM-Tg-bovg-IP2112-Ab-2 | Anti-Bovine ™EM56 monoclonal antibody | Bovine |
GM-Tg-equg-IP2112-Ab-1/ GM-Tg-equg-IP2112-Ab-2 | Anti-Equine ™EM56 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2112-Ab-1/ GM-Tg-hg-IP2112-Ab-2; GM-Tg-rg-IP2112-Ab-1/ GM-Tg-rg-IP2112-Ab-2; GM-Tg-mg-IP2112-Ab-1/ GM-Tg-mg-IP2112-Ab-2; GM-Tg-cynog-IP2112-Ab-1/ GM-Tg-cynog-IP2112-Ab-2; GM-Tg-felg-IP2112-Ab-1/ GM-Tg-felg-IP2112-Ab-2; GM-Tg-cang-IP2112-Ab-1/ GM-Tg-cang-IP2112-Ab-2; GM-Tg-bovg-IP2112-Ab-1/ GM-Tg-bovg-IP2112-Ab-2; GM-Tg-equg-IP2112-Ab-1/ GM-Tg-equg-IP2112-Ab-2 |
Products Name | Anti-™EM56 monoclonal antibody |
Format | mab |
Target Name | ™EM56 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-™EM56 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2112-Ag-1 | Recombinant multi-species TLCD4/ ™EM56 protein |
ORF Viral Vector | pGMLP003102 | human ™EM56 Lentivirus plasmid |
ORF Viral Vector | vGMLP003102 | human ™EM56 Lentivirus particle |
ORF Viral Vector | pGMLPm002829 | mouse Tmem56 Lentivirus plasmid |
ORF Viral Vector | vGMLPm002829 | mouse Tmem56 Lentivirus particle |
Target information
Target ID | GM-IP2112 |
Target Name | ™EM56 |
Gene ID | 148534,99887,365924,709729,101080312,100057932 |
Gene Symbol and Synonyms | 4930577M16Rik,C730036B01Rik,RGD1563041,TLCD4,™EM56 |
Uniprot Accession | Q96MV1 |
Uniprot Entry Name | TLCD4_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000152078 |
Target Classification | N/A |
The target: ™EM56, gene name: ™EM56, also named as . Predicted to be involved in lipid homeostasis. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.